Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: Insights from the Framingham Study

被引:29
作者
Kannel W.B. [1 ]
Wolf P.A. [1 ]
机构
[1] Framingham Heart Study, Framingham, MA 01702-5827
关键词
Peripheral Arterial Disease; Peripheral Artery Disease; Intermittent Claudication; Vascular Territory; Framingham Study;
D O I
10.1007/s11883-006-0010-3
中图分类号
学科分类号
摘要
Major risk factors or clinical atherosclerosis include dyslipidemia, hypertension, glucose intolerance, adiposity, cigarette smoking, hemostatic factors, inflammatory markers, and sedentary lifestyle. Sets of some of these and evidence of vascular damage such as left ventricular hypertrophy and atrial fibrillation are used to formulate multivariable risk profiles for peripheral artery disease and stroke. These global risk formulations facilitate office estimation of the risk of these disabling diseases, which often indicate diffuse systemic atherosclerosis. Because predisposing risk factors usually cluster, and the risk each imposes varies widely, global risk assessment is a necessity, especially now that average risk factor levels are recommended for treatment. Novel risk factors deserve attention, but the standard cardiovascular risk factors account for as much as 85% of the cardiovascular disease arising within the population. Further improvement in detection, evaluation, and control of the major risk factors by implementation of guidelines for primary and secondary prevention of stroke and peripheral artery disease is needed, particularly in the high-risk segment of the population. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:317 / 323
页数:6
相关论文
共 42 条
[1]  
Cupples L.A., D'Agostino R.B., Survival Following Initial Cardiovascular Events, (1988)
[2]  
Kannel W.B., Global cardiovascular risk evaluation, Preventive Cardiology. A Practical Approach, pp. 1-21, (2005)
[3]  
NHLBI Chart Book on Cardiovascular Lung and Blood Diseases, (2002)
[4]  
Hiatt W.R., Medical treatment of peripheral arterial disease, N Engl J Med, 344, pp. 1608-1621, (2001)
[5]  
Thom T.J., Stroke mortality trends: An international perspective, Ann Epidemiol, 3, pp. 509-518, (1993)
[6]  
American Heart Association 2004 Heart Disease and Stroke Statistics-2004 Update, (2004)
[7]  
Hylek E.M., Go A.S., Chang Y., Et al., Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation, N Engl J Med, 349, pp. 1019-1026, (2003)
[8]  
Kannel W.B., McGee D.L., Update on some epidemiologic features of intermittent claudication, J Am Geriatr Soc, 33, pp. 13-18, (1985)
[9]  
Kannel W.B., Risk factors for atherosclerotic cardiovascular outcomes in different vascular territories, J Cardiovasc Risk, 1, pp. 1-7, (1994)
[10]  
Murabito J.M., Evans J.C., D'Agostino R.B., Et al., Temporal trends of intermittent claudication from 1950-1999, Am J Epidemiol, 162, pp. 430-437, (2005)